The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors

Abstract

Copay assistance reduced the patient cost burden for ALKi's and was associated with patients picking up their ALKi prescriptions, beginning ALKi treatment sooner, and remaining on treatment.